Equitech International Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$572.38 | $591.94 | 8.32% | 1 | $218.49B |
| DHR | Danaher | Outperform |
10
|
$248.38 | $260.33 | 9.68% | 4 | $183.97B |
| A | Agilent Technologies | Outperform |
10
|
$139.45 | $138.82 | 8.28% | 10 | $40.87B |
| MTD | Mettler-Toledo International | Hold |
13
|
$1.25k | $1.12k | -2.47% | 0 | $26.78B |
| WAT | Waters | Hold |
15
|
$321.25 | $323.50 | 2.72% | 2 | $19.05B |
| ILMN | Illumina | Outperform |
16
|
$117.93 | $159.28 | 27.19% | 9 | $18.78B |
| AVTR | Avantor | Outperform |
16
|
$24.72 | $23.25 | 13.27% | 19 | $16.79B |
| PKI | PerkinElmer | Outperform |
16
|
$100.61 | $121.84 | 23.13% | 1 | $12.49B |
| BRKR | Bruker | Outperform |
16
|
$70.05 | $73.64 | 29.19% | 1 | $10.18B |
| BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$279.83 | $536.80 | 50.09% | 1 | $7.74B |
| COHR | Coherent | - |
12
|
$33.97 | $258.00 | -100.00% | 0 | $6.61B |
| LAB | Standard BioTools | Buy |
11
|
$2.51 | $4.00 | 39.44% | 1 | $948.50M |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$1.83 | $12.67 | 91.26% | 4 | $449.37M |
| HBIO | Harvard Bioscience | Buy |
14
|
$3.85 | $7.00 | 81.82% | 2 | $165.87M |
| ENZ | Enzo Biochem | - |
8
|
$1.36 | $5.50 | -100.00% | 0 | $62.10M |
| DYXC | DiaSys | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.03M |
| ASPT | Haber | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.02M |
| MDIT | Medite Cancer Diagnostics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.01M |
| OMRX | Orthometrix | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
| LFPI | LifePoint | - |
0
|
$0.00 | $5.50 | 0.00% | 0 | $0.00M |